(env) as well as various smaller open reading frames encoding regulatory proteins (12) . In cats experimentally infected with FIV, an antibody response against the structural proteins can be detected 2 to 4 weeks after infection (5) . Antibodies directed against the envelope surface glycoprotein can be detected first, immediately followed by antibodies to the viral core proteins p15 and p24, respectively. Diagnosis of FIV infection is currently based on assays that primarily detect antibodies to the gag proteins (6, 11, 15) , although some infected cats lack a significant antibody response to these proteins (5) . In this article we describe the cloning of the gag and env genes of the virus isolate FIV-UT113 into the genome of the baculovirusAutographa californica nuclear polyhedrosis virus (AcNPV). High levels of expression of both envelope and core precursor proteins were obtained in the baculovirus system. The env gene expression product was further characterized and used, in combination with the gag gene product, to develop an assay for the detection of anti-FIV antibodies in cat sera.
MATERIALS AND METHODS
Cells and viruses. Spodoptera frugiperda Sf9 cells (ATCC CRL 1711) were grown in monolayer cultures at 27°C in TC100 medium (Gibco BRL) supplemented with 10% fetal calf serum, 50 ,ug of gentamicin per ml, and 2.5 ,ug of fungizone per ml. Cell culture procedures and virus manipulations were performed essentially as described by Summers and Smith (17) .
Construction of baculovirus transfer vectors. All DNA techniques used were based on those of Ausubel (1 (17) . Recombinant baculoviruses were purified by several rounds of limiting dilution as described by Goswami and Glazer (7). High-titer stocks (>107 PFU/ml) were prepared and used to infect Sf9 monolayers.
Labeling of expression products. Sf9 cells were seeded in a culture dish and allowed to attach for 2 h. The cells were infected with recombinant baculovirus at a multiplicity of infection of 5 and incubated for 2 days at 27°C. The culture medium was removed and replaced by methionine-free medium. The cells were preincubated for 1 h, and the medium was replaced by 0. (ELISA) in microtiter plates coated with lysates of Sf9 cells expressing these products. Baculovirus-infected cells were harvested 72 h after infection by low-speed centrifugation. They were washed once with phosphate-buffered saline (PBS) and resuspended in PBS-0.25% SDS to a concentration of 2 x 107 cells per ml. The suspension was boiled for 5 min, followed by removal of cell debris (15 min, Eppendorf centrifuge, 15,000 rpm), and the supematant was used for coating of the wells. Optimal antigen dilution was determined by titration; a 1:1,500 dilution of the antigen in PBS was routinely used. The format of this ELISA consisted of three wells coated with lysates of cells expressing the envelope glycoprotein precursor, expressing the gag precursor, or infected with the wild-type (WT) baculovirus, respectively. Each well was coated with 100 ,1 of antigen dilution. The plates were incubated overnight at 4°C, washed three times with PBS-0.05% Tween 20 and blocked for 1 h with 10% skim milk powder-0.5% Tween 20-0.2 M NaCl in PBS (PTN) at 37°C. They were then washed three times with PBS-Tween, and 100 ,ul of serum dilution (in PTN) was added to each well, followed by 1 h of incubation at 37°C. After three washes with PBS-Tween, a 1:7,500 dilution (in PTN) of peroxidase-conjugated goat anti-cat immunoglobulin G (Cappel Research Products) was added (100 Rl per well) and the plates were incubated 1 h at 37°C. Finally, they were washed five times with PBS and the substrate-chromogen solution (0.01% tetramethyl benzidine-0.006% H202-0. Fig. 1 . The gag precursor protein migrated as a band with an estimated size of 50 kDa (p50) which corresponds to the native molecule in FIV-infected cells (4, 16) and to data from Morikawa et al. (10) . The env gene expression product migrated as a broad band and had an estimated size of 130 kDa. No recombinant envelope glycoproteins could be detected in the culture medium; however, a small amount of p50 was found (not shown) probably representing virus-like particles consisting of unprocessed p50 (10) .
The envelope precursor of FIV is N-glycosylated and partially processed in insect cells. The env gene expression product was characterized by endoglycosidase digestion (Fig. 2) . Expression products were labeled and incubated with serum, and the immunoprecipitates were treated with endoglycosidase H (lane 2) or endoglycosidase F/N-glycosidase F (lane 3). Labeling of cells infected with vBE23 resulted in the synthesis of two glycoprotein species with estimated molecular sizes of 150 and 130 kDa, respectively. Two other protein species of 65 and 35 kDa are detectable, the latter slightly glycosylated, but these cannot be identified as FIV related. Glycosidase treatment of the gpl50 and gpl30 glycoproteins resulted in a shift in molecular sizes to about 100 and 80 kDa, respectively. Slight molecular size differences observed between lanes 2 and 3 are due to different enzymatic activities of the glycosidases used.
To investigate whether gplS0 and gpl30 are related, we performed pulse-chase labeling on vBE23 infected cells. The results are shown in Fig. 3 . Longer chase periods (up to 24 h) resulted in the gradual disappearance of gplS0 while the amount of gpl30 appeared to increase in time, suggesting that gplS0 is a precursor molecule of gpl30.
Immune responses to FIV in experimentally infected cats.
Sera from four experimentally infected cats obtained at different time points were examined by ELISA for antibodies directed against the envelope and core proteins of FIV. Cats 320 and 340 were infected with a Dutch isolate (FIV-UT48), while cats 199 and 201 were infected with FIVPetaluma, the prototype strain isolated in the United States (13) . As can be seen in Fig. 4 , all cats seroconverted within 3 to 4 weeks, with anti-envelope antibodies detectable first. Three out of four cats showed comparable immune responses during the course of infection. In these cats the anti-envelope antibody titers remained higher than those against the core. Cat 320 had a different antibody response, with the anti-core antibody titer showing a very strong increase until 10 weeks postinfection, even exceeding the anti-envelope titers. The core-antibody titers dropped after 4 months, while anti-envelope titers continued to increase.
Use of the ELISA for screening of sera from naturally infected cats. To evaluate the ELISA for its use in routine antibody screening, we tested 206 serum samples from naturally infected cats. All sera had been prescreened in our laboratory by an immunofluorescence assay (IFA) on FIV-UT113-infected Crandell feline kidney (CRFK) cells (2) . Positive sera and sera that had given ambiguous results in the fluorescence assay were also screened by Western blot (immunoblot) (WB). Sucrose gradient-purified FIV that had lost most of its envelope surface glycoprotein was used to prepare the nitrocellulose strips. Thus, WB analysis was primarily based on the detection of antibodies directed against the other structural proteins, primarily core proteins. To reduce the effects of aspecific binding of feline antibodies to the microtiter plate, we used a high serum dilution (1:500) in combination with a blocking solution containing 10% skim milk powder, 0.5% Tween 20, and 0.35 M NaCl. IFA and WB analysis of the 206 serum samples resulted in 108 negative reactions, 84 positive reactions, and 14 ambiguous reactions. The last group were from sera that had given weak reactions with plO or p24 in WB. The ELISA results are summarized in Table 1 . Most FIV-positive sera (98%) had an optical density at 450 nm in the env or gag ELISA which was 2 to 10 times the background value measured in the wells coated with lysate from WT AcNPV-infected cells. However, 2% of the sera gave high background values (optical density at 450 nm > 0.5). This prevented the use of more commonly accepted criteria such as a cutoff limit of twice the background value, since this would falsely assign FIV-positive, high-background sera as FIV negative. To circumvent this problem, we subtracted the WT optical density readings from the env and gag ELISA values and used the resultant AENV or AGAG figures to define the cutoff limit. The limit was empirically set at 0.04. When this low cutoff value was used, the ELISA results closely correlated with the IFA-WB results. Ninety-three serum samples were scored ELISA positive: 45 serum samples by both AENV and AGAG ELISA, 46 serum samples by AENV ELISA, and 2 serum samples by the AGAG ELISA only. However, four serum samples scored positive by ELISA and negative in the IFA-WB tests and two serum samples tested negative by ELISA and positive in the IFA-WB tests. Of the 14 serum samples reacting ambiguously by IFA-WB, 7 tested positive and 7 tested negative by ELISA.
All 20 serum samples (14 ambiguously reacting in IFA-WB, 4 ELISA positive and IFA negative, and 2 ELISA negative and IFA and WB positive) were further examined by using a radioimmunoprecipitation assay (RIPA) with labeled FIV-UT113 virus. The 14 serum samples with ambiguous reactions by IFA-WB gave RIPA results that were in agreement with the ELISA scores; also, the seropositivity of two of the four ELISA-positive and IFA-WB-negative sera was confirmed. Both serum samples that had tested negative by ELISA but positive by IFA-WB were confirmed as negative in the RIPA. In conclusion, only 2 out of 206 samples (0.97%) were falsely FIV seropositive, and no serum from FIV-infected cats escaped detection.
Interestingly, RIPA analysis of these 20 serum samples resulted in the characterization of several serum samples that had no or only low levels of antibodies directed against the p17 and p24 core proteins (Fig. 5, lanes 4 to 10) . In the ELISA, 2 of the 206 sera were AENV negative but AGAG positive, thereby suggesting a lack of anti-envelope antibodies. However, in RIPA they precipitated the pl7/p24 gag proteins and also reacted with the envelope glycoprotein (Fig. 5, lane 3) . (10) who also showed the absence of processing of the gag precursor to the core proteins p10, p17, and p24. The env gene translation product was also expressed at a high level in our insect cell system. The envelope precursor appeared a glycoprotein of 150 kDa that was slowly processed to a glycoprotein of 130 kDa. Removal The results obtained with our ELISA and in confirmatory RIPA emphasize the necessity to include the screening for anti-envelope and anti-core protein antibodies in one diagnostic assay. Enlarging upon previously reported data (5), we have clear evidence for FIV-infected cats that possess very low amounts of antibodies directed against the core proteins p17 and p24 or even completely lack anti-core antibodies. Seven out of 91 FIV-positive serum samples (7.7%) lacked anti-core antibodies (or had low titers) and were thus prone to be overlooked in assays that are based on the detection of these antibodies (6, 11, 15) . The presence of sera that did not react with the envelope expression product in the ELISA but had a strong anti-core response (2.2%) underscores the necessity of screening for antibodies to both viral proteins. processing of the primary env gene translation product to the envelope precursor, gpl30, in FIV-infected CRFK cells (19) but occurs at a much slower rate in insect cells. No evidence of further cleavage of the envelope precursor into the surface envelope (gplOO) and transmembrane glycoproteins (gp35) was found. The latter cleavage was also lacking in the HIV-1 envelope precursor expressed in insect cells (8) but was apparent in the bovine immunodeficiency virus envelope precursor (14) .
The recombinant core and envelope proteins were used to develop an ELISA for antibody detection in FIV-infected cats. A low cutoff value was defined for the detection of FIV-positive sera. Although this may result in erroneously identifying cats as FIV positive, this was not the case in our assay. The test had a greater fidelity than the IFA combined with the confirmatory WB assay. Only 2 out of 206 serum samples (0.97%) tested falsely positive, whereas all FIV seropositive cats, as examined by IFA, WB, and/or RIPA, were detected. This resulted in a very high sensitivity (percentage of positive sera that tested positive) and specificity (percentage of negative sera that also scored negative in the ELISA) for this test: 100% and 99%, respectively. It is very important to avoid false-negative results. Seronegative animals are not routinely retested in a confirmatory assay, and FIV-infected cats that escape detection at the first testing can continue to be a source of FIV infection in the cat population. In contrast, IFA-WB screening of the sera resulted in 4 false-positive or false-negative serum samples (1.9%) and 14 serum samples that could not be classified positive or negative (6.8%).
